Drug Shortage Report for PENICILLIN G SODIUM FOR INJECTION, USP
Report ID | 1772 |
Drug Identification Number | 01930680 |
Brand name | PENICILLIN G SODIUM FOR INJECTION, USP |
Common or Proper name | PENICILLIN G SODIUM |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PENICILLIN G SODIUM |
Strength(s) | 10000000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 |
ATC code | J01CE |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-01-25 |
Estimated end date | 2022-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-02-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-02-13 | French | Compare |
v6 | 2020-02-13 | English | Compare |
v5 | 2020-02-13 | English | Compare |
v4 | 2017-10-10 | French | Compare |
v3 | 2017-10-10 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 7 of 7